Assessment of myocardial viability using perfusion cardiac spet imaging. tiiallium-201 rest/redistribution, tiiallium-201 rest/reinjection and technetium-99m tetrofosmin rest/postnitrates;Valoración de la viabilidad miocárdica mediante SPET cardiaco de perfusion. Talio-201 reposo/redistribución, talio-201 reposo/reinyección y tecnecio-99m tetrofosmina reposo/posnitratos

Revista Espanola de Cardiologia

Volumn 51, Issue SUPPL. 1, 1998, Pages 45-52

  Giralt, Albert Flotats ^a   Gasset, Ignasi Carrió ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; THALLIUM;

AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CLINICAL PROTOCOLS; CORONARY CIRCULATION; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0031602134     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117:211-213.
2. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982; 66: 1.146-1.149.
3. Bonow RO, Epstein SE. Indications for coronary artery bypass surgery: implications of the multicenter randomized trials. Circulation 1982; 66: 562-568.
4. Iskandrian AS, Heo J, Stanberry C. When is myocardial viability an important clinical issue? J Nucl Med 1994; 35 (Supl): 4-7.
5. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993; 87: 1-20.
6. Tamaki N, Kawamoto M, Tamadura E, Magata Y, Yonekura Y, Nohara R et al. Prediction of reversible ischemia after revascularization: perfusion and metabolic studies with positron emission tomography. Circulation 1995:91: 1.694-1.705.
7. Hendel RC. Single photon perfusion imaging for the assessment of myocardial viability. J Nucl Med 1994; 35 (Supl): 23-31.
8. He ZX, Verani MS, Liu XJ. Nitrate-augmented myocardial imaging for assessment of myocardial viability. J Nucl Cardiol 1995; 2: 352-357.
9. García MJ. Utilización de nitratos en la valoración de viabilidad miocardica mediante SPECT de perfusion. Rev Esp Med Nucl 1996; 4: 250-256.
10. He ZX, Darcourt J, Guignier A, Ferrari E, Bussière F, Bandovy M et al. Nitrates improve detection of ischémie but viable myocardium by thallium-201 reinjection SPECT. J Nucl Med 1993; 34: 1.472-1.477.
11. Bisi G, Sciagrà R, Santoro GM, Zerauschek F, Fazzini PF. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility. J Nucl Med 1994; 35: 1.274-1.278.
12. Bisi G, Sciagrà R, Santoro GM, Rossi V, Fazzini PF. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict recovery. J Nucl Med 1995; 36: 1.994-2.000.
13. Maurea S, Cuocolo A, Soricelli A, Catelli L, Nappi A, Squame F et al. Enhanced detection of viable myocardium by technetium99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995; 36: 1.945-1.952.
14. Sciagrà R, Bisi G, Santoro GM, Agnolucci M, Zoccarato O, Fazzini PF. Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labeled sestamibi single-photon emission computed tomography. J Nucl Cardiol 1996; 3: 221-230.
15. Pereztol O, Valdés JA, Batista JF, López D, Sánchez E, Pérez B. Comparación de las imdgenes de WmTc-MIBI reposo y ""TcMIBI NTG SPET: posibles implicaciones en la detección de la viabilidad miocardica. Rev Esp Med Nucl 1996; 4: 221-227.
16. Zaret BL, Rigo P, Wackers FJT, Hendel RC, Braat SH, Iskandrian AS et al. Myocardial perfusion imaging with w"Tc-tetrofosmin. Comparison to 2'T1 imaging and coronary angiography in a phase III multicenter trial. Circulation 1995; 91: 313-319.
17. Flotats A, Carrió I, Estorch M, Berna LI, Catafau AM, Man C et al. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography. Eur J Nucl Med 1997; 24: 767-773.
18. Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL. Identification of viable myocardium in patients with coronary artery disease and left ventricular dysfunction: comparison of thallium scintigraphy with reinjection and PET imaging with '8F-fluorodeoxyglucose. Circulation 1991; 83: 26-37.
19. Dilzisian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM et al. Concordance and disconcordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessment of viable myocardium. Circulation 1993; 88: 941-952.
20. Matsunari I, Fulino S, Taki J, Senma J, Aoyama T, Wakasugi T et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995; 36: 1.961-1.967.
21. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99mtetrofosmin myocardial imaging: a comparison with thallium-201 and angiography. J Nucl Med 1994; 35: 587-593.
22. Tamaki N, Takahashi N, Kawamoto M, Torizuka T, Tadamura T, Yonekura Y et al. Myocardial tomography using technetium99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35: 594-600.
23. Rozanski A, Berman DS, Gray R, Levy R, Raymond M, Maddahi J et al. Use of thallium-201 redistribution scintigraphy in the pre-operative differentiation of reversible and non reversible myocardial asynergy. Circulation 1981; 64: 936-944.
24. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL et al. Myocardial viability in patients with chronic coronary artery disease. Comparison of WnlTc-sestamibi with thallium reinjection and ["F]Fluorodeoxyglucose. Circulation 1994; 89: 578-587.
25. Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxybutylisonitrile. J Nucl Med 1992; 33: 505-511.
26. Marzullo P, Sambuceti G, Parodi O. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. J Nucl Med 1992; 33: 1.925-1.930.
27. Marzullo P, Sambuceti G, Parodi O, Gimelli A, Picano E, Giorgetti A et al. Regional concordance and disconcordance between rest thallium 201 and sestamibi imaging for assessing tissue viability: comparison with postrevascularization functional recovery. J Nucl Cardiol 1995; 2: 309-316.
28. Udelson JE, Coleman PS, Matherall JA, Pandian NG, Gomez AR, Griffith JL et al. Predicting recovery of severe regional ventricular dysfunction: comparison of resting scintigraphy with thallium-201 and technetium-99m sestamibi. Circulation 1994; 89: 2.552-2.561.
29. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution ^'Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1.630-1.641.
30. Dilsizian V, Rocco T, Freedman NMT, Leon MB, Bonow RO. Enhanced detection of ischémie but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
31. Dilsizian V, Smeltzer WR, Freedman NMT, Dextras R, Bonow RO. Thallium reinjection after stress-redistribution imaging. Does 24-hour delayed imaging after reinjection enhance detection of viable myocardium? Circulation 1991; 83: 1.247-1.255.
32. Dilsizian V, Bonow RO. Differential uptake and apparent thallium-201 washout after thallium reinjection: options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection. Circulation 1992; 85: 1.032-1.038.
33. Nelson CW, Wilson RA, Angello DA, Palac RT. Effect of thallium-201 blood levels on reversible myocardial defects. J Nucl Med 1989; 30: 1.172-1.175.
34. Castell J, Gonzalez JM, Fraile M, Garci'a-Burillo A, Aguadé S, Ysamat M et al. Sestamibi uptake quantification predicting recovery of severe regional ventricular dysfunction [resumen]. J Nucl Cardiol 1995; 2 (Supl): 21.
35. Platts EA, North TL, Pickett RD, Kelly JD. Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol 1995; 2:317-326.
36. Younès A, Songadele JA, Maublant J, Platts E, Pickett R, Veyre A. Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 1995; 2: 327-333.